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There is increasing evidence that the cutaneous neu-
rosensory system can directly modulate in¯amma-
tory responses in the skin by the release of
neuropeptides such as substance P (SP). Dermal
microvascular endothelial cell (DMEC) cellular adhe-
sion molecule (CAM) expression plays a key role in
directing leukocyte traf®cking during cutaneous
in¯ammatory responses. In recent studies, our
laboratory examined the direct effect of SP on
DMEC CAM expression and function in vitro and in
vivo. Our studies indicate that DMEC express high
af®nity functional receptors for SP. After exposure
to SP, DMEC expressed signi®cant levels of both
intercellular adhesion molecule 1 (ICAM-1) and vas-
cular cell adhesion molecule-1 (VCAM-1), which was
accompanied by increased binding to leukocytes
expressing the appropriate integrin counter receptors
for these CAM. We then determined the in vivo effect
of released neuropeptides on DMEC CAM expres-
sion. Our results indicate that the topical cutaneous
application of the neuropeptide-releasing agent cap-
saicin resulted in increased ICAM-1 and VCAM-1
immunostaining of microvascular cells in the skin of
human volunteers. Little is known regarding the cel-
lular regulatory events by which SP modulates
DMEC CAM expression. Our studies indicate that
SP-induced cellular Ca+2 signals led to the activation
of the NF-kB pathway, resulting in nuclear translo-
cation of p65/p50 heterodimers that bind to high-
af®nity tandem kB sites on the VCAM-1 promoter,
whereas SP activation induced NF-AT activation and
ICAM-1 DNA binding. Thus, these studies further
support the role of the cutaneous neurologic system
in modulating in¯ammatory processes in the skin.
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T
here is signi®cant evidence that the cutaneous
neurologic system can mediate in¯ammatory re-
sponses in the skin through the release of speci®c
neuropeptides that can interact with various epider-
mal and dermal target cells. The close physical
association of cutaneous nerves with these target cells has been
clearly established (Weisner-Menzel et al, 1981; Wang et al, 1990;
Hosoi et al, 1993). It has been appreciated that neuropeptides such
as substance P (SP) and calcitonin gene related peptide (CGRP)
have a number of vasoactive properties, including vasodilation,
increased microvascular permeability, and protein extravasation
(Erjavec et al, 1981; Brain et al, 1986). Additionally, SP can induce
leukocyte effector activities such as lymphocyte proliferation,
immunoglobulin production, cytotoxicity, mast cell degranulation,
PMN and macrophage activation, and cytokine production by
monocytes (Hartung and Toyka, 1983; Payan et al, 1983; Kimball
et al, 1988; Lotz et al, 1988; Wiederman et al, 1989; McGillis et al,
1991; Ansel et al, 1996, 1997; Scholzen et al, 1998). We have
previously shown that SP can directly activate mast cells and
keratinocytes to secrete TNFa and IL-1, respectively (Brown et al,
1990; Ansel et al, 1993; Song et al 2000). We have recently
examined the role of the cutaneous neurologic system in the
modulation of certain proin¯ammatory functions by cutaneous
microvascular endothelial cells.
A critical component of the initiation and evolution of localized
in¯ammation is the homing and extravasation of leukocytes at the
sites of tissue injury, which is fundamentally directed by the
expression of cell adhesion molecules (Caughman, 1991; Carlos
and Harlan, 1994). Leukocyte±endothelial adhesion interactions
leading to extravasation are based on a sequential series of events
requiring regulated expression of multiple adhesion proteins by
endothelial cells including E-selectin, intercellular adhesion mole-
cule 1 (ICAM-1), and vascular cell adhesion molecule-1 (VCAM-
1) (Rothlein et al, 1986; Bevilacqua et al, 1987; Rice and Munro,
1990). The assessment of cutaneous neuropeptide modulation of
human dermal microvascular endothelial cell (HDMEC) cellular
adhesion molecule (CAM) expression is important to our under-
standing of interactions between the cutaneous neurologic system
and skin in¯ammatory responses. Indeed, HDMEC perform a key
gatekeeper function in the initiation, modulation, and termination
of in¯ammatory responses in the skin. In¯ammatory in®ltration of
leukocytes into all tissues, including the skin, depends on leukocyte
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passage into tissue from the microvasculature in a multi-step
binding interaction involving CAM expressed by leukocytes and
endothelial cells (Lawrence and Springer, 1991; von Andrian et al,
1991). P-selectins and E-selectins mediate initial leukocyte
adhesion of HDMEC through binding to speci®c carbohydrate
complexes present on neutrophils, whereas ICAM-1 and VCAM-1
mediate subsequent ®rm adhesion and transendothelial migration
by binding to b2 and b1-integrins on leukocytes.
SP REGULATION OF HDMEC ICAM-1 EXPRESSION
AND FUNCTION
In the skin, HDMEC expression of ICAM-1 is an essential
component of cutaneous in¯ammation. ICAM-1 is constitutively
expressed in vitro by HDMEC. The proin¯ammatory cytokines,
interferon-g, TNFa, and IL-1 as well as UVB irradiation, increase
ICAM-1 surface expression (Swerlick et al, 1991; Cornelius et al,
1994). Understanding how neuropeptides regulate HDMEC
surface ICAM-1 expression will advance our knowledge of
important initiating events in cutaneous in¯ammation. In a
previous study, it was reported that SP was capable of upregulating
ICAM-1 on cultured large vessel human umbilical vein endothelial
cells (HUVEC). This study did not, however, examine the effect of
SP on dermal microvascular endothelial cells in vitro or in vivo, and
neuropeptide receptors were not characterized (Nakagawa et al,
1993). Because all tissue in¯ammatory responses in the skin and
elsewhere are mediated by microvascular endothelial cell activities
rather than by large vessel endothelial cells, and because the two cell
types display distinct differences in their phenotypes and responses
to proin¯ammatory signals (Swerlick and Lawley, 1993), it is
essential to measure neuroin¯ammatory responses in HDMEC
(Quinlan et al, 1998).
Recent studies in our laboratory indicate that cultured HDMEC
express mRNA for the neurokinin receptors NK1R, NK2R, and
NK3R, which are capable of binding to SP with high,
intermediate, and low af®nities, respectively (Quinlan et al,
1998). Our studies indicate that SP induces a rapid intracellular
Ca+2 response in HDMEC and that this effect is mediated primarily
by NK1R. In vivo, immunohistochemistry studies demonstrate that
the NK1R is the major neurokinin receptor expressed on dermal
microvascular endothelial cells. HDMEC activation by SP is
accompanied by increased levels of ICAM-1 mRNA and ICAM-1
cell surface expression. The optimal increase in HDMEC ICAM-1
occurs 16±18 h after exposure to SP. Flow cytometric analysis of
ICAM-1 expression of SP-treated HDMEC indicates that induc-
tion is mediated primarily by the NK1R (Fig 1). The functional
consequences of SP induction of cell surface ICAM-1 on binding
of J-Y lymphoblastoid cells to HDMEC were determined in vitro
using a quantitative cellular adhesion assay. Our results indicate that
the addition of SP resulted in a signi®cant increase in J-Y cell
adhesion to cultured HDMEC. The adhesion of these leukocytes to
SP-treated HDMEC could be prevented by pretreatment of
HDMEC with an anti-ICAM-1 blocking antibody before the
addition of labeled J-Y cells.
The effect of in vivo release of cutaneous neuropeptides on
HDMEC ICAM-1 expression was also examined. A capsaicin
containing cream, Zostrix, was applied to the skin of human
volunteers to stimulate the release of cutaneous neuropeptides
including SP from cutaneous sensory nerves (Fig 2). Low
constitutive levels of microvascular ICAM-1 expression were
observed in untreated skin. Microvascular ICAM-1 expression
gradually increases at 6 h, markedly increases by 24 h, and remains
upregulated even at 48 h after topical application of capsaicin. Thus,
the in vivo release of neuropeptides by cutaneous sensory nerves
results in increased microvascular endothelial ICAM-1 expression.
Thus, our studies demonstrated that SP is capable of directly
modulating HDMEC ICAM-1 expression and function by the
activation of speci®c cell surface neurokinin receptors. There is also
evidence that SP can mediate indirect induction of endothelial cell
CAM expression. Murphy and others have demonstrated that SP
treatment of skin explants caused mast cell degranulation and
subsequent TNFa mediated induction of E-selectin on postcapil-
lary venular endothelial cells (Matis et al, 1990). In active cutaneous
in¯ammation, we therefore propose that SP may in¯uence dermal
microvascular cell CAM expression both directly and indirectly
through the activation of other target cells in the skin.
SP DIRECTLY AND SPECIFICALLY UPREGULATES
VCAM-1 EXPRESSION ON HDMEC
In the skin, the expression of speci®c combinations of adhesion
molecules is closely regulated and correlates with the selective
recruitment of leukocyte subtypes. The biologic functions of
adhesion molecules ICAM-1 and VCAM-1 are distinct. Unlike
ICAM-1, which is widely distributed on antigen presenting cells,
epithelial cells, and ®broblasts, in the skin cell surface expression of
VCAM-1 is mainly restricted to the vascular endothelium
(Elangbam et al, 1997), though its expression and role on other
cell types in other tissues has been described (Iademarco et al, 1993;
Lukacs et al, 1994; Yellin et al, 1995). Therefore, we also examined
the effect of different cutaneous nerve-released neuropeptides on
microvascular endothelial cell VCAM-1 expression and function
(Quinlan et al, 1999a).
To determine the in vivo effect of C-®ber released neuropeptides
on HDMEC VCAM-1 expression, capsaicin cream was applied
topically to human volunteers to stimulate the release of
neuropeptides including SP. Our results indicate that increased
VCAM-1 immunoreactivity could be detected by 6 h after
capsaicin application, with peak expression at 24 h and decreased
expression 48 h after treatment. Thus, the release of neuropeptides
by cutaneous sensory nerves results in increased HDMEC VCAM-
1 expression in vivo.
Because a number of neuropeptides are detected in normal and
in¯amed skin, the direct effect of these different neuropeptides on
HDMEC VCAM-1 was tested in vitro (Fig 3) (Quinlan et al,
1999a). Untreated HDMEC express little or no cell surface
VCAM-1. SP was able to induce a dose dependent increase (up
to 7-fold) in HDMEC VCAM-1 expression. Optimal expression of
Figure 1. Flow cytometric analysis of ICAM-1 expression of SP-
treated HDMEC. Surface expression of ICAM-1 on HDMEC was also
assessed by ¯ow cytometric analysis at 18 h after exposure to NK-1RA
followed by 100 nM SP (bottom left), 100 nM SP (top right), or 300 m
per ml TNFa (bottom right). Open histogram areas under solid lines
represent constitutive ICAM-1 expression (Untx Ctrl); superimposed ®lled
histogram areas represent expression with treatments indicated by heavier
solid lines in keys. Top left shows untreated cells incubated with an isotype
control IgG in place of the anti-ICAM-1 antibody. The data are
representative of experiments conducted in triplicate. (Published in
Quinlan et al, 1998.)
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HDMEC VCAM-1 occurred 16 h after the addition of SP. In
contrast, under similar experimental conditions, incubation with
neurokinin A (NKA), neurokinin B (NKB), neurotensin (NT),
calcitonin gene related peptide (CGRP), and somatostatin (SMA)
had no effect on HDMEC VCAM-1 induction. We then
determined if SP directly upregulates the expression of HDMEC
VCAM-1 or whether this was in part due to the induction by SP of
HDMEC-secreted soluble factors that in turn could be responsible
for increased VCAM-1 expression. Our studies indicate that the
induction of HDMEC VCAM-1 expression could be completely
abrogated by the addition of anti-SP antibodies to the culture
supernatant of SP-treated HDMEC, which strongly supports the
direct effect of SP on HDMEC VCAM-1 expression.
The biologic consequence of SP-induced HDMEC VCAM-1
cell surface expression was determined using a quantitative cellular
adhesion assay with Molt-4 T cells that express the speci®c counter
receptor ligand for VCAM-1. The addition of 10 nM SP induced a
4-fold increase in the adhesion of Molt-4 cells to HDMEC, which
was blocked by pretreating cells with a speci®c antibody to
VCAM-1. Thus, these studies further support the role of
neuropeptides in the regulation of leukocyte traf®cking in the skin.
TRANSCRIPTIONAL MECHANISMS BY WHICH SP
MODULATES CELLULAR ADHESION MOLECULE GENE
EXPRESSION IN HDMEC
SP mediates its effects on target cells by binding to cell surface G-
protein coupled neurokinin receptors. SP binds to a high-af®nity
receptor, NK1R, which we have detected in HDMEC.
Engagement of the NK1R with SP results in an increase in
intracellular Ca+2 levels, followed by an increase in expression of
HDMEC ICAM-1 and VCAM-1. As little is known of the
regulatory events by which SP modulates adhesion gene expression,
however, we have conducted gene transcription studies to better
understand this mechanism (Quinlan et al, 1999b).
The ®nal targets of cell surface signals are often the activated
proteins that associate with DNA regulatory elements and regulate
transcription. ICAM-1 and VCAM-1 are highly regulated at the
transcriptional level by a number of mediators (Neish et al, 1992;
Marui et al, 1993; Cornelius et al, 1994; Gille et al, 1996; Duff et al,
1997; Paxton et al, 1997). Transcription of ICAM-1 and VCAM-1
induced by TNFa is modulated by distinct members of the Rel
family. NF-kB is retained in the cytoplasm in an inactive form by
the inhibitory protein IkB, which in turn is regulated by the IkB
kinase, IKK (Israel, 1997). Following a variety of extracellular
stimuli, NK-kB dissociates from IkB, translocates to the nucleus,
and activates a number of target genes. The minimal DNA binding
domain of NF-kB (p65/p50) on the ICAM-1 promotor
corresponds exactly to the NF-AT high-af®nity consensus site
(TGGAAA) (Prieschl et al, 1995; Rooney et al, 1995; Tsytsykova
et al, 1996). Within particular NF-kB DNA binding domains, an
NF-AT monomer can bind to the 5¢ half-site of the DNA binding
domain, and a second NF-AT monomer can bind to the
symmetrical 3¢ half-site, which is why NF-AT transcription factors
are often termed monomeric Rel proteins (Rao et al, 1997). NF-
AT is expressed in most immune cells and like NK-kB, plays a
pivotal role in the transcription of genes critical for in¯ammatory
responses.
We have identi®ed the SP-activated transcription factors that
associate with the DNA binding domains of the ICAM-1 and
VCAM-1 regulatory regions in HDMEC (Fig 4). Our studies have
demonstrated SP-mediated activation results in both NF-AT
binding to the ±191/±170 of ICAM-1 and NF-kB (p65/p50)
binding to the ±76/±52 of VCAM-1 genes. These events were
speci®cally blocked by both the NK1R antagonist and by
cyclosporine A (CsA). Although NF-AT is associated with
heterologous DNA binding proteins, especially AP-1, SP-driven
NF-AT/ICAM-1 appears in vitro to lack cooperative binding with
Figure 2. In vivo induction of HDMEC ICAM-1 expression. Photomicrographs were taken of human skin biopsies immunostained for ICAM-1
expression after topical capsaicin application to release cutaneous neuropeptides. Arrows point to dermal microvascular structures. Human skin was left
untreated (A) or treated with capsaicin cream (0.075%) and biopsied at 6 h (B), 24 h (C), or 48 h (D). (Published in Quinlan et al, 1998.)
Figure 3. ELISA measurement of VCAM-1 expression of neuropep-
tide-treated HDMEC. HDMEC were stimulated with 1, 10, 100, or
1000 nM of either SP, neurokinin A (NKA), neurokinin B (NKB),
neurotensin (NT), calcitonin gene-related peptide (CGRP), or somato-
statin (Sms). TNFa, 300 U per ml, was utilized as a positive control.
Incubations were for 16 h at 37°C and cell surface VCAM-1 was measured
by ELISA. Statistically signi®cant differences in cell surface VCAM-1 in
treated samples as compared with untreated control cells (±) were
determined by Student's t test as indicated by (*) (p < 0.005). The data
shown are representative of experiments conducted in triplicate. (Published
in Quinlan et al, 1999a.)
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transcription factors of the AP-1 family. While it is possible that
cooperation with other transcription factors may occur in vivo, our
site-directed mutagenesis studies show that the NF-AT site, which
overlaps with the 5¢ portion of the p65 homodimer NF-kB binding
site, abrogates both SP- and TNFa-induced transcription, even
within the context of the remaining native ICAM-1 promoter.
Our data also indicate that SP-elicited intracellular Ca+2 mobiliza-
tion is required for both NF-AT and NF-kB activation and binding
to their respective consensus sites on the ICAM-1 and VCAM-1
genes. This is in contrast to the TNFa-activated NF-kB pathway,
which is Ca
+2
independent. Thus, this provides further evidence
that SP and TNFa modulate CAM transcription via distinct
signaling pathways. There are recent reports of the requirement of
intracellular Ca+2 mobilization for NF-kB activation and kB-
dependent gene expression in other cell types and by signals other
than neuropeptides (Pahl et al, 1996; Sun and Carpenter, 1998).
CONCLUSION
HDMEC are essential participants of the human cutaneous
in¯ammatory system. These cells express both soluble and cell-
associated proin¯ammatory molecules that play a key role in the
recruitment and traf®cking of various types of leukocytes into the
dermis and epidermis during in¯ammatory skin diseases. The
expression and function of HDMEC ICAM-1 and VCAM-1 seem
to be required for normal leukocyte responses in the skin by
facilitating adhesion and transmigration into the extravascular
compartment of the skin. Our recent studies demonstrate that
released neuropeptides such as SP can directly modulate the
expression of HDMEC CAM both in vitro and in vivo. Thus, our
studies further support the concept that the cutaneous neurologic
system can regulate key aspects of in¯ammatory processes in the
skin.
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